Literature DB >> 18056340

Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell.

Joseph A Wahle1, Kim H T Paraiso, Robert D Kendig, Harshani R Lawrence, Liwei Chen, Jerry Wu, William G Kerr.   

Abstract

We have previously demonstrated that the NKR repertoire is profoundly disrupted by SHIP deficiency. This repertoire disruption is characterized by receptor dominance where inhibitory signals from 2B4 repress killing of complex targets expressing MHC class I and activating ligands. In this study, we examine the molecular basis of receptor dominance in SHIP-/- NK cells. In this study, we show that in SHIP-/- NK cells there is a pronounced bias toward the 2B4 long isoform. We have also characterized signaling molecules recruited to 2B4 in SHIP-/- NK cells. Interestingly, we find that approximately 10- to 16-fold more Src homology region 2 domain-containing phosphatase 1 (SHP1) is recruited to 2B4 in SHIP-/- NK cells when compared with wild type. Consistent with SHP1 overrecruitment, treatment with sodium orthovanadate or a novel inhibitor with micromolar activity against SHP1 restores the ability of SHIP-/- NK cells to kill Rae1+ RMA and M157+ targets. These findings define the molecular basis for hyporesponsiveness by SHIP-deficient NK cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056340     DOI: 10.4049/jimmunol.179.12.8009

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.

Authors:  Michelle M Collazo; Kim H T Paraiso; Mi-Young Park; Amy L Hazen; William G Kerr
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

2.  Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells.

Authors:  Zhongjun Dong; Mario-Ernesto Cruz-Munoz; Ming-Chao Zhong; Riyan Chen; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

Review 3.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

4.  SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in mice.

Authors:  Matthew Gumbleton; Eric Vivier; William G Kerr
Journal:  J Immunol       Date:  2015-02-16       Impact factor: 5.422

5.  Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.

Authors:  Gwenny M Fuhler; Robert Brooks; Bonnie Toms; Sonia Iyer; Elizabeth A Gengo; Mi-Young Park; Matthew Gumbleton; Dennis R Viernes; John D Chisholm; William G Kerr
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

6.  Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.

Authors:  Eun-Ok Kim; Tae-Jin Kim; Nayoung Kim; Sung Tae Kim; Vinay Kumar; Kyung-Mi Lee
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

7.  Mouse natural killer cell development and maturation are differentially regulated by SHIP-1.

Authors:  Cindy Banh; S M Shahjahan Miah; William G Kerr; Laurent Brossay
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

Review 8.  Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes.

Authors:  Wai-Hang Leung; Tatyana Tarasenko; Silvia Bolland
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

9.  Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.

Authors:  S Liu; H Zhang; M Li; D Hu; C Li; B Ge; B Jin; Z Fan
Journal:  Cell Death Differ       Date:  2012-11-16       Impact factor: 15.828

Review 10.  A role for SHIP in stem cell biology and transplantation.

Authors:  William G Kerr
Journal:  Curr Stem Cell Res Ther       Date:  2008-05       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.